Mar 14, 2007
By:
Beth Herskovits
Drug giant streamlines professional advertising but remains coy about sales force headcount.
|
Mar 14, 2007
By:
Beth Herskovits
Swiss drug maker gears up to launch first in class Tekturna.
|
Mar 7, 2007
By:
Beth Herskovits
Third regulatory delay highlights difficulty of developing weight loss products.
|
Mar 7, 2007
By:
Beth Herskovits
HRT franchise grows despite lawsuits, new safety fears.
|
Mar 7, 2007
By:
Beth Herskovits
Pharma is forging more partnerships with technology companies to extend patent life.
|
|
The industry is at a crossroads, and all eyes are on the world's largest drug maker. When Pfizer leads, others follow. So we asked: If you had that sort of influence, how would you steer Big Pharma?
Mar 1, 2007
By:
Beth Herskovits
When Pfizer CEO Jeffrey Kindler took the podium in January and announced that the struggling company would scale back and restructure its operations, he did more than just signal the end of an era. He proved that to turn around Pfizer—and in a way, the industry at large—companies need to hack away the parts that just aren't working anymore.
|
Feb 28, 2007
By:
Beth Herskovits
Unbranded effort with American Cancer Society will bolster patient education, compliance.
|
Feb 28, 2007
By:
Beth Herskovits
Companies like Amgen, J&J launch DTC efforts to raise awareness of biologics.
|
Feb 28, 2007
By:
Beth Herskovits
Merck ends controversial lobbying campaign for HPV vaccine, but was it the right move?
|
|